Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Cardiac Surgery"
DOI: 10.1111/jocs.17063
Abstract: Recent changes in the market for left ventricular assist devices have resulted in the HeartMate 3 (HM3) being the only commercially‐available device. This study evaluates the outcomes of patients with a HM3 waitlisted for and…
read more here.
Keywords:
ventricular assist;
heartmate left;
device strategy;
assist device ... See more keywords